🇺🇸 FDA
Patent

US 8147805

Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications

granted A61KA61K47/549A61K47/61

Quick answer

US patent 8147805 (Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications) held by The Board of Regents of the University of Texas System expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K47/549, A61K47/61, A61K49/0002, A61K49/0438